Hologic Inc (OQ:HOLX)
Business Focus: Advanced Medical Equipment & Technology
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 250 Campus Drive MARLBOROUGH MA 1752 |
| Tel: | 1-858-4108514 |
| Website: | https://www.hologic.com |
| IR: | See website |
| Key People | ||
| Stephen P. Macmillan Chairman of the Board, President, Chief Executive Officer | Karleen Marie Oberton Chief Financial Officer | Erik S. Anderson Division President - Breast and Skeletal Health Solutions |
| Jennifer Schneiders President - Diagnostic Solutions | Brandon Schnittker Division President, GYN Surgical Solutions | Jan Valeer Verstreken Group President - International |
| Essex D. Mitchell Chief Operating Officer | Peter P. Dunne Senior Vice President - Human Resources | John M. Griffin General Counsel |
| Business Overview |
| Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD. |
| Financial Overview |
| For the three months ended 30 December 2023, Hologic Inc revenues decreased 6% to $1.01B. Net income increased 32% to $246.5M. Revenues reflect Diagnostics segment decrease of 20% to $447.8M, Skeltal Health segment decrease of 5% to $25.4M, United States segment decrease of 8% to $753.7M, Europe segment decrease of 3% to $142.8M. Net income reflects Breast Health segment income increase of 69% to $102.2M. |
| Employees: | 6,990 as of Sep 30, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $18,274M as of Dec 30, 2023 |
| Annual revenue (TTM): | $3,969M as of Dec 30, 2023 |
| EBITDA (TTM): | $1,230M as of Dec 30, 2023 |
| Net annual income (TTM): | $515.10M as of Dec 30, 2023 |
| Free cash flow (TTM): | $858.70M as of Dec 30, 2023 |
| Net Debt Last Fiscal Year: | $645.90M as of Dec 30, 2023 |
| Shares outstanding: | 234,731,521 as of Jan 25, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.